This site looks better in landscape mode! Turn your device on its side!

AKLRD develops novel solutions for inflammatory diseases with a high unmet need

Over 50%

Over half of people diagnosed with knee osteoarthritis are under 65 years of age

NEWS

New studies suggests APPA protects against joint damage

Read More

NEWS

APPA Phase II human study completes ahead of schedule

Read More

NEWS

Personalised Medicine & Disease Modification in OA

Read More